Epilepsy

Reading File
Asking for Preferences
Finding Sources
Finding Sources
Searching PubMed

"epilepsy" AND "management"

Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Loading Image
Loading Image

Epilepsy - Comprehensive Medical Student Review


1. Definition

Epilepsy is a disease of the brain defined by the 2014 ILAE criteria as any ONE of:
  1. At least two unprovoked (or reflex) seizures occurring >24 hours apart
  2. One unprovoked seizure with a probability of further seizures ≥60% over the next 10 years (e.g., after a single seizure with a structural lesion on MRI, or epileptiform EEG)
  3. Diagnosis of an epilepsy syndrome
Key distinction: A seizure is a single event of abnormal excessive hypersynchronous neuronal activity. Epilepsy is the underlying disease predisposing to recurrent seizures. Provoked seizures (e.g., alcohol withdrawal, hypoglycemia, hyponatremia) are not epilepsy.
  • Bradley and Daroff's Neurology in Clinical Practice

2. Pathophysiology

The Paroxysmal Depolarizing Shift (PDS)

The fundamental cellular event is the paroxysmal depolarizing shift - a massive, prolonged depolarization of neurons in a seizure focus driven by:
  • AMPA- and NMDA-type glutamate receptor-channels (excitatory input)
  • Voltage-gated Ca²⁺ channels (gCa) amplifying depolarization
  • Followed by hyperpolarization via: GABA-A receptors (Cl⁻), GABA-B receptors (K⁺), and Ca²⁺-activated K⁺ channels (gK)
The PDS represents exaggerated excitation in a seizure focus. The afterhyperpolarization normally limits seizure duration. When it fails, seizures propagate.
Paroxysmal Depolarizing Shift - AMPA, GABA, gCa, gK, NMDA conductances underlying the PDS
The conductances underlying the PDS: AMPA and NMDA drive depolarization; GABA and gK drive the afterhyperpolarization. - Eric Kandel, Principles of Neural Science, 6th Ed.

Seizure Spread

Focal and generalized seizure spread via cortical, transcallosal and thalamic pathways
  • Focal seizure: Starts in a focus, spreads via intrahemispheric fibers (1), to homotopic contralateral cortex via corpus callosum (2), and to subcortical centers (3)
  • Secondary generalization: Thalamic involvement (4) propagates activity to both hemispheres simultaneously
  • Primary generalized seizure: Both hemispheres activated simultaneously from onset via thalamocortical circuits (Panel B above)
Eric Kandel, Principles of Neural Science, 6th Ed.

Imbalance Summary (Exam High-Yield)

MechanismResult
↑ Glutamate (AMPA/NMDA)↑ Excitation → seizure
↓ GABA-A/B function↓ Inhibition → seizure
Na⁺ channel dysfunctionRepetitive firing
T-type Ca²⁺ channel ↑Absence seizures (thalamocortical circuits)

3. ILAE Classification (2017) - Three Levels

The 2017 ILAE framework has three levels. Classification at all three is ideal but not always achievable.
Level 1: SEIZURE TYPE
        ↓
Level 2: EPILEPSY TYPE  
        ↓
Level 3: EPILEPSY SYNDROME
        + ETIOLOGY (at every level)
        + COMORBIDITIES

Level 1 - Seizure Types

A. Focal-Onset Seizures (arise from one hemisphere)

  • Focal aware (previously "simple partial") - consciousness preserved
  • Focal impaired awareness (previously "complex partial") - consciousness impaired
  • Focal to bilateral tonic-clonic (previously "secondarily generalized")
Focal features by lobe of origin:
LobeTypical Features
TemporalAura (déjà vu, rising epigastric sensation), automatisms (lip-smacking, hand fumbling), post-ictal confusion
FrontalMotor signs, brief seizures, nocturnal, may generalize rapidly
ParietalSensory symptoms, tingling, numbness
OccipitalVisual hallucinations (lights, colors)

B. Generalized-Onset Seizures (both hemispheres from onset)

TypeKey Features
Absence (typical)Sudden behavioral arrest + staring, 3-20 sec, no post-ictal phase, 3 Hz spike-wave on EEG
Absence (atypical)Slower onset/offset, often in Lennox-Gastaut syndrome
MyoclonicBrief (<100 ms) involuntary muscle jerks; morning predominance in JME
TonicSustained muscle contraction, trunk/limb stiffening
ClonicRhythmic jerking movements
Tonic-clonic (GTC)Tonic phase → clonic phase; post-ictal drowsiness/confusion
AtonicSudden loss of muscle tone ("drop attacks")
Epileptic spasmsWest syndrome; flexion/extension of trunk

C. Unknown Onset

Level 2 - Epilepsy Types

  • Focal epilepsy
  • Generalized epilepsy
  • Combined generalized and focal (e.g., Dravet syndrome)
  • Unknown

Level 3 - Common Epilepsy Syndromes (High-Yield)

SyndromeAge of OnsetSeizure TypeEEGKey Feature
Childhood Absence Epilepsy (CAE)4-8 yrTypical absence3 Hz generalized spike-waveHyperventilation triggers; ethosuximide/valproate
Juvenile Myoclonic Epilepsy (JME)AdolescenceMyoclonic + GTC ± absence4-6 Hz polyspike-wave; morningLifelong treatment usually needed
Benign Rolandic Epilepsy (BECTS)3-13 yrFocal sensorimotor face/armCentrotemporal spikesOften outgrown by puberty
West Syndrome3-7 monthsEpileptic spasms (clusters)HypsarrhythmiaACTH/vigabatrin treatment
Lennox-Gastaut Syndrome1-7 yrMultiple types (tonic, atonic, absence)Slow (<2.5 Hz) spike-waveDevelopmental regression, refractory
Dravet Syndrome<1 yrFebrile + afebrile GTCPolyspike-waveSCN1A mutation; sodium channel blockers WORSEN it
Temporal Lobe Epilepsy (TLE)AnyFocal impaired awareness + GTCTemporal spikes/sharp wavesMost common adult focal epilepsy; mesial TLE with hippocampal sclerosis

4. Etiology

The ILAE 2017 framework emphasizes identifying the etiology at every classification level:
Etiology CategoryExamples
StructuralHippocampal sclerosis, cortical dysplasia, tumors, stroke, trauma, encephalitis
GeneticSCN1A (Dravet), KCNQ2, DEPDC5, chromosomal (Down, Angelman)
InfectiousNeurocysticercosis, HSV encephalitis, HIV
MetabolicPyridoxine deficiency, mitochondrial disease, PKU
ImmuneAnti-NMDAR encephalitis, LGI1, CASPR2 antibodies
Unknown~50% of all epilepsies

5. Clinical Assessment & Diagnosis

History (most important diagnostic tool)

  • Full description of the episode (from witness): onset, progression, duration
  • Pre-ictal aura (points to focal onset)
  • Ictal features: automatisms, motor activity, eye deviation, head turn
  • Post-ictal: confusion (Todd's paralysis, aphasia), duration
  • Provoking factors, sleep deprivation, alcohol, medications
  • Family history, birth history, febrile seizures

EEG (Electroencephalogram)

  • Interictal EEG: Spike-and-wave discharges between seizures
    • 3 Hz generalized spike-wave = absence epilepsy
    • Centrotemporal spikes = BECTS
    • Hypsarrhythmia = West syndrome
    • Focal temporal spikes = TLE
  • Ictal EEG: Rhythmic activity corresponding to clinical seizure
  • EEG is normal in 50% of patients with epilepsy on a routine interictal recording
  • Sleep deprivation, hyperventilation, and photic stimulation are activation procedures
  • EEG bands: delta (0.5-4 Hz), theta (4-7 Hz), alpha (8-13 Hz), beta (13-30 Hz)

Neuroimaging

  • MRI brain (preferred over CT): Structural causes (hippocampal sclerosis, tumors, dysplasia)
  • FLAIR and T2 sequences most sensitive for cortical abnormalities
  • CT head: Used acutely to exclude hemorrhage/mass

Initial Investigations for New-Onset Seizures

  • Blood glucose, electrolytes (Na⁺, Ca²⁺, Mg²⁺), renal/liver function, FBC
  • Toxicology screen
  • EEG
  • MRI brain
  • LP if encephalitis/meningitis suspected

6. Antiseizure Medications (ASMs) - High-Yield Table

DrugMechanismIndicationsKey Adverse Effects
Valproic acidNa⁺ channel + GABA ↑ + T-Ca²⁺ ↓ + NMDA ↓ (multiple)Focal + generalized + absenceHepatotoxicity, teratogen (neural tube defects), weight gain, thrombocytopenia, pancreatitis
PhenytoinNa⁺ channel inhibitorFocal + generalizedZero-order kinetics, gingival hyperplasia, hirsutism, nystagmus, ataxia, Stevens-Johnson syndrome; hepatic enzyme inducer
CarbamazepineNa⁺ channel inhibitorFocal + GTC; TNHyponatremia (SIADH), diplopia, SJS (HLA-B*1502 in Asian patients); enzyme inducer
OxcarbazepineNa⁺ channel inhibitorFocal seizuresLess enzyme induction than CBZ; hyponatremia
LamotrigineNa⁺ channel inhibitorFocal + generalizedRash (slow titration prevents SJS); slow dose escalation needed; enzyme inducer
LevetiracetamSV2A modulationFocal + generalizedMood disturbance, irritability, psychosis; minimal drug interactions
BrivaracetamSV2A modulation (higher affinity)Focal + generalizedLess psychiatric side effects than levetiracetam
EthosuximideT-type Ca²⁺ channel ↓Absence seizures onlyGI upset, headache; NOT effective for focal seizures
TopiramateNa⁺ + GABA ↑ + AMPA ↓ + Ca²⁺ ↓Focal + generalizedCognitive impairment ("Dopamax"), nephrolithiasis, weight loss, glaucoma
PhenobarbitalGABA-A potentiationFocal + generalizedSedation, cognitive effects; enzyme inducer
LacosamideNa⁺ channel (slow inactivation)Focal + generalizedPR interval prolongation
ZonisamideNa⁺ + Ca²⁺ channelsFocal + generalizedNephrolithiasis, cognitive effects, weight loss
VigabatrinIrreversible GABA-T inhibitorInfantile spasms (1st-line); focalIrreversible peripheral visual field loss
PerampanelAMPA receptor antagonistFocal + generalizedDizziness, psychiatric effects
Gabapentin/Pregabalinα2δ Ca²⁺ channel subunitFocal seizures (adjunct)Sedation, weight gain
Adams and Victor's Principles of Neurology, 12th Ed.; Eric Kandel, Principles of Neural Science, 6th Ed.

Drug Selection Principles (High-Yield)

  • Absence epilepsy: Ethosuximide (1st-line pure absence), Valproate (if GTC also present)
  • Focal epilepsy: Carbamazepine or Lamotrigine (1st-line)
  • JME: Valproate (most effective), Lamotrigine, Levetiracetam
  • Dravet syndrome: AVOID Na⁺ channel blockers (phenytoin, carbamazepine, lamotrigine - they worsen); use valproate, clobazam, topiramate
  • Infantile spasms (West syndrome): ACTH or prednisolone (1st-line); vigabatrin (especially in TSC)
  • Women of childbearing age: Avoid valproate if possible (teratogenicity); lamotrigine preferred

7. Management Principles

When to Start Treatment

  • After two unprovoked seizures - start ASM
  • After one seizure with high recurrence risk (structural lesion, epileptiform EEG, epilepsy syndrome)
  • After one seizure alone - treatment not automatically required

Monotherapy First

  • Start with a single ASM at low dose and titrate
  • Failure of two appropriately chosen and dosed ASMs defines drug-resistant epilepsy (~30% of patients)

Drug-Resistant Epilepsy

  • Surgical evaluation is the 1st-line treatment for drug-resistant focal epilepsy
  • Most common surgery: Anterior temporal lobectomy (for mesial TLE)
  • Other surgical options: Corpus callosotomy (drop attacks), hemispherectomy
  • Neuromodulation: Vagus nerve stimulation (VNS), responsive neurostimulation (RNS), deep brain stimulation (DBS - anterior nucleus of thalamus)
  • Ketogenic diet: High-fat, low-carbohydrate; especially useful in pediatric drug-resistant epilepsy

Stopping ASMs

  • Typically considered after 2 years seizure-free
  • EEG guides decision - normal EEG = better prognosis
  • Gradual taper over weeks-months
  • Discuss driving implications

8. Status Epilepticus (SE)

Definition: Seizure lasting ≥5 minutes, OR two or more seizures without full recovery between them.
Convulsive SE lasting >30 min carries mortality up to 20%.

Most Common Cause

  • Non-compliance with ASM (most common cause of tonic-clonic SE)

Management Protocol (Time-Critical)

0-5 min:  ABCs, IV access, O2, glucose, vitals, bloods
          Benzodiazepine (FIRST-LINE):
          - IV Lorazepam 0.1 mg/kg (drug of FIRST choice in hospital)
          - IM Midazolam (out-of-hospital or no IV access)
          - Rectal Diazepam (community)

5-20 min: If seizure continues → SECOND-LINE:
          - IV Levetiracetam, OR
          - IV Valproate, OR
          - IV Phenytoin/Fosphenytoin

20-40 min: If refractory SE → THIRD-LINE:
           - Anaesthetic doses: Propofol, Thiopental, Midazolam infusion
           - ICU admission, EEG monitoring

Super-refractory SE (>24h despite anaesthesia):
           - Ketamine, Ketogenic diet, Immunotherapy
Plum and Posner's Diagnosis and Treatment of Stupor and Coma; Swanson's Family Medicine Review

9. Special Situations

Epilepsy in Pregnancy

  • Discuss contraception - enzyme-inducing ASMs (phenytoin, carbamazepine, phenobarbital) reduce efficacy of oral contraceptives
  • Valproate has highest teratogenic risk (10x neural tube defects, neurodevelopmental effects) - avoid if possible
  • Lamotrigine and levetiracetam are preferred in pregnancy
  • Folic acid supplementation (5 mg/day) for all women on ASMs planning pregnancy
  • AAN/AES 2024 Practice Guideline (PMID: 38748979): confirms teratogenesis risk hierarchy and recommends shared decision-making

Sudden Unexpected Death in Epilepsy (SUDEP)

  • Leading cause of epilepsy-related death
  • Rate: ~1 in 1000 person-years; higher in drug-resistant epilepsy
  • Mechanism: Postictal cardiorespiratory failure, possibly postictal generalized EEG suppression
  • Risk reduction: Better seizure control, avoid nocturnal seizures, use of safety pillows

Non-Epileptic Attack Disorder (NEAD / PNES)

  • Psychogenic non-epileptic seizures (PNES) - must be distinguished from epilepsy
  • Often present with motor seizures but no EEG correlate
  • Video-EEG monitoring is the gold standard for diagnosis

10. Exam High-Yield Summary

TopicKey Fact
ILAE 2014 definition2 unprovoked seizures, OR 1 seizure with ≥60% recurrence risk
Single seizure rule"A single seizure does not epilepsy make"
3 Hz spike-wave EEGChildhood absence epilepsy
HypsarrhythmiaWest syndrome (infantile spasms)
Na⁺ channel blockers WORSENDravet syndrome (SCN1A mutation)
1st choice for absence onlyEthosuximide
1st choice SE (IV)Lorazepam
Teratogen with highest riskValproate
Drug-resistant epilepsy defined byFailure of 2 adequate trials of ASMs
Most common adult focal epilepsyMesial temporal lobe epilepsy (hippocampal sclerosis)
JME characteristic timeMorning myoclonic jerks after waking
Vigabatrin irreversible toxicityVisual field loss (bilateral)
Surgery for drug-resistant focalAnterior temporal lobectomy

Sources: Bradley and Daroff's Neurology in Clinical Practice; Eric Kandel, Principles of Neural Science, 6th Ed.; Adams and Victor's Principles of Neurology, 12th Ed.; AAN/AES Practice Guideline 2024 (PMID: 38748979)
This is a shared conversation. Sign in to Orris to start your own chat.